Development and validation of a population pharmacokinetic model for lacosamide in adult patients with epilepsy to inform precision dosing
Abstract Background Lacosamide is a third-generation antiseizure medication that reduces seizures by promoting slow inactivation of voltage-gated sodium channels. There are significant interindividual differences in the pharmacokinetics of this drug. The aim of this study was to explore the pharmaco...
| 出版年: | BMC Pharmacology and Toxicology |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
BMC
2026-03-01
|
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s40360-026-01114-2 |